Metformin Ameliorates Hepatic Steatosis induced by olanzapine through inhibiting LXRα/PCSK9 pathway

Zhu, W., Ding, C., Huang, P., Ran, J., Lian, P., Tang, Y., Dai, W., & Huang, X. (2022). Metformin Ameliorates Hepatic Steatosis induced by olanzapine through inhibiting LXRα/PCSK9 pathway. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-09610-1

Authors:

Wenqiang Zhu

Chen Ding

Piaopiao Huang

Juanli Ran

Pingan Lian

Yaxin Tang

Wen Dai

Xiansheng Huang

Affiliated Authors:

Wen Dai

Columbia Affiliation:

Vagelos College of Physicians and Surgeons
- Department of Medicine
  Seymour, Paul and Gloria Milstein Division of Cardiology

Subjects:

Metformin (MeSH)

Non-alcoholic Fatty Liver Disease (MeSH)

Epidemiology and Management of NAFLD (OpenAlex Topic)

Cholesterol Metabolism and Atherosclerosis (OpenAlex Topic)

Impact of Fructose on Metabolic Health (OpenAlex Topic)

Publication Type:

Article

Unique ID:

10.1038/s41598-022-09610-1

PMID:

DOI:

10.1038/s41598-022-09610-1

Journal:

Scientific Reports

Publication Date:

2022-12-01

Data Source:

Scopus

Source Link:

View Scopus Record

View OpenAlex Record

View PubMed Record

View Web of Science Record

Record Created:

Thursday, September 12, 2024 - 09:54